BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26490636)

  • 1. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells.
    Berga-Bolaños R; Zhu WS; Steinke FC; Xue HH; Sen JM
    Mol Immunol; 2015 Dec; 68(2 Pt B):484-9. PubMed ID: 26490636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity.
    Xing S; Li F; Zeng Z; Zhao Y; Yu S; Shan Q; Li Y; Phillips FC; Maina PK; Qi HH; Liu C; Zhu J; Pope RM; Musselman CA; Zeng C; Peng W; Xue HH
    Nat Immunol; 2016 Jun; 17(6):695-703. PubMed ID: 27111144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells.
    Xing S; Gai K; Li X; Shao P; Zeng Z; Zhao X; Zhao X; Chen X; Paradee WJ; Meyerholz DK; Peng W; Xue HH
    J Exp Med; 2019 Apr; 216(4):847-866. PubMed ID: 30837262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
    Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
    PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.
    Steinke FC; Xue HH
    Immunol Res; 2014 Aug; 59(1-3):45-55. PubMed ID: 24847765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf1 and Lef1 provide constant supervision to mature CD8
    Shan Q; Li X; Chen X; Zeng Z; Zhu S; Gai K; Peng W; Xue HH
    Nat Commun; 2021 Oct; 12(1):5863. PubMed ID: 34615872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.
    Yang BH; Wang K; Wan S; Liang Y; Yuan X; Dong Y; Cho S; Xu W; Jepsen K; Feng GS; Lu LF; Xue HH; Fu W
    Cell Rep; 2019 Jun; 27(12):3629-3645.e6. PubMed ID: 31216480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
    Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
    Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation.
    Carr T; Krishnamoorthy V; Yu S; Xue HH; Kee BL; Verykokakis M
    J Exp Med; 2015 May; 212(5):793-807. PubMed ID: 25897173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
    Noma H; Eshima K; Satoh M; Iwabuchi K
    Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell factor-1 controls the lifetime of CD4+ CD8+ thymocytes in vivo and distal T cell receptor α-chain rearrangement required for NKT cell development.
    Sharma A; Berga-Bolaños R; Sen JM
    PLoS One; 2014; 9(12):e115803. PubMed ID: 25536344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T
    Li F; Zhao X; Zhang Y; Shao P; Ma X; Paradee WJ; Liu C; Wang J; Xue HH
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SLAM in NKT cell development revealed by transgenic complementation in NOD mice.
    Jordan MA; Fletcher JM; Jose R; Chowdhury S; Gerlach N; Allison J; Baxter AG
    J Immunol; 2011 Apr; 186(7):3953-65. PubMed ID: 21357537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.
    Ma G; Yasunaga J; Akari H; Matsuoka M
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2216-21. PubMed ID: 25646419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network of high-mobility group box transcription factors programs innate interleukin-17 production.
    Malhotra N; Narayan K; Cho OH; Sylvia KE; Yin C; Melichar H; Rashighi M; Lefebvre V; Harris JE; Berg LJ; Kang J;
    Immunity; 2013 Apr; 38(4):681-93. PubMed ID: 23562159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.
    Ngai H; Barragan GA; Tian G; Balzeau JC; Zhang C; Courtney AN; Guo L; Xu X; Wood MS; Drabek JM; Demberg T; Sands CM; Chauvin-Fleurence CN; Di Pierro EJ; Rosen JM; Metelitsa LS
    Cancer Immunol Res; 2023 Feb; 11(2):171-183. PubMed ID: 36484736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.
    Okamura RM; Sigvardsson M; Galceran J; Verbeek S; Clevers H; Grosschedl R
    Immunity; 1998 Jan; 8(1):11-20. PubMed ID: 9462507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.
    Kafka A; Bačić M; Tomas D; Žarković K; Bukovac A; Njirić N; Mrak G; Krsnik Ž; Pećina-Šlaus N
    J Cell Mol Med; 2019 Jan; 23(1):641-655. PubMed ID: 30468298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tcf1 Sustains the Expression of Multiple Regulators in Promoting Early Natural Killer Cell Development.
    Liu J; Wang Z; Hao S; Wang F; Yao Y; Zhang Y; Zhao Y; Guo W; Yu G; Ma X; Liu J; Chen F; Yuan S; Kang Y; Yu S
    Front Immunol; 2021; 12():791220. PubMed ID: 34917097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.